About Daniel Diniz De Carvalho
Daniel Diniz De Carvalho is Adela's co-founder and chief scientific officer. Adela develops blood tests for cancer monitoring and early detection. He originally developed its platform at University Health Network's Princess Margaret Cancer Centre with Sinai Health System investigators.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Diniz De Carvalho in the role, so the role may have started earlier or lasted longer.
Adela, Inc. Current
Co-Founder and Chief Scientific Officer
2023 – Present · Foster City, CA
Adela's blood tests help clinicians detect recurrence and drug developers study treatment response.
Key Colleagues at Startups
The people Daniel Diniz De Carvalho works with at each company, as listed on that company's latest Form D.
Adela, Inc. · Form D, Oct 19, 2026
LM
Lindsay Mateo
Chief Executive Officer and director
DB
David Bonita
Director
PB
Paul Brown
Director
AH
Anne-Renee Hartman
Co-Founder and Chief Medical Officer
Maneesh Jain
Director
DS
David Scheer
Chairman of Adela's Board of Directors
Robert Weisskoff
Director
AW
Alan Williams
Executive officer
AK
Abraham Kometz
Director